This webinar is designed to give an overview of the Pilot Clinical Trial Simulation Tool developed by Critical Path Institute’s Type 1 Diabetes Consortium. This regulatory-grade tool is intended to influence trial design in new-onset T1D by enabling clinical trial simulation using one of three univariate models: C-peptide, HbA1c or insulin. The C-peptide model is under review by FDA and has not yet approved. The models are subject to change based on FDA feedback. Please visit our T1D consortium page to learn more at c-path.org/t1d.
